Target & Activity
| Target | Activity | Value |
|---|---|---|
| ALK | IC50 | 0.62nM |
| FER | IC50 | 1.3nM |
| ROS/ROS1 | IC50 | 1.9nM |
| FLT3 | IC50 | 2.1nM |
| FES/FPS | IC50 | 3.4nM |
| FAK/PTK2 | IC50 | 3.8nM |
| BRK | IC50 | 4.1nM |
| STK22D | IC50 | 4.3nM |
| Chk2 | IC50 | 6.5nM |
| RSK2 | IC50 | 13nM |
| TYK/LTK | IC50 | 13nM |
| YES | IC50 | 19nM |
| PYK2 | IC50 | 24nM |
| ErbB4 | IC50 | 27nM |
| CLK1 | IC50 | 29nM |
| CaMKIId | IC50 | 29nM |
| Chk1 | IC50 | 30nM |
| RSK1 | IC50 | 30nM |
| RSK4 | IC50 | 42nM |
| IRR/INSRR | IC50 | 45nM |
| IGF-1R | IC50 | 46nM |
| ARK5 | IC50 | 47nM |
| CaMKIIg | IC50 | 48nM |
| LRRK2 | IC50 | 51nM |
| FRK | IC50 | 52nM |
| FLT4 | IC50 | 58nM |
| RET | IC50 | 65nM |
| CaMKK2 | IC50 | 83nM |
| MARK2 | IC50 | 94nM |
| PKCnu | IC50 | 95nM |
| PHKg2 | IC50 | 108nM |
| LOK/STK10 | IC50 | 123nM |
| BRSK2 | IC50 | 125nM |
| MARK3 | IC50 | 127nM |
| MARK1 | IC50 | 127nM |
| FGFR1 | IC50 | 128nM |
| EGFR | IC50 | 129nM |
| BLK | IC50 | 136nM |
| TSSK2 | IC50 | 138nM |
| AuroraA | IC50 | 146nM |
| JAK2 | IC50 | 154nM |
| FGFR4 | IC50 | 181nM |
| PKCmu/PKD1 | IC50 | 197nM |
| Fyn | IC50 | 198nM |
| Hck | IC50 | 198nM |
| MLK1/MAP3K9 | IC50 | 218nM |
| FGFR2 | IC50 | 228nM |
| CLK2 | IC50 | 240nM |
| Lyn | IC50 | 241nM |
| PKD2/PRKD2 | IC50 | 285nM |
| c-Src | IC50 | 329nM |
| BRSK1 | IC50 | 338nM |
| FGFR3 | IC50 | 358nM |
| Fms | IC50 | 358nM |
| InsulinReceptor | IC50 | 395nM |
| SIK2/SNF1LK2/QIK | IC50 | 466nM |
| FGR | IC50 | 491nM |
| TAOK1 | IC50 | 492nM |
| Abl1 | IC50 | 500nM |
| LCK | IC50 | 512nM |
| PLK1 | IC50 | 611nM |
| BTK | IC50 | 673nM[null] |
62 targets · Scroll to view more
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| BaF3 | IC50 | 12 nM | Inhibition of EML4-ALK F1174L mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 12 nM | Inhibition of EML4-ALK S1206Y mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 142 nM | Inhibition of EML4-ALK 1151Tins mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 1921 nM | Cytotoxicity against mouse BA/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 2 nM | Inhibition of EML4-ALK G1269A mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 2300 nM | Inhibition of EML4-ALK L1152R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 28.4 nM | Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay | [PMID: 33243531] |
| BaF3 | IC50 | 3 nM | Inhibition of EML4-ALK C1156Y mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 3 nM | Inhibition of EML4-ALK L1196M mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 5 nM | Inhibition of wild type EML4-ALK (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 56 nM | Inhibition of EML4-ALK G1202R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as cell viability after 72 hrs by MTS assay | [PMID: 26568289] |
| BaF3 | IC50 | 59.1 nM | Cytotoxicity against mouse BaF3 cells expressing human EGFR C797S/T790M/del19 mutant assessed as inhibition of in cell viability measured after 72 hrs by CellTiter-Glo assay | [PMID: 33243531] |
| KARPAS-299 | IC50 | 41.5 nM | Antiproliferative activity against human ALK-positive KARPAS299 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution cell proliferation assay | [PMID: 27144831] |
| Kelly | EC50 | 127 nM | Antiproliferative activity against human Kelly cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
| NCI-H3122 | EC50 | 5 nM | Antiproliferative activity against human NCI-H3122 cells after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
| SH-SY5Y | EC50 | 986 nM | Antiproliferative activity against human SH-SY5Y cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
| SK-N-AS | EC50 | 776 nM | Antiproliferative activity against human SK-N-AS cells expressing wild type EML4-ALK after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
| SK-N-FI | EC50 | 2645 nM | Antiproliferative activity against human SK-N-FI cells expressing wild type EML4-ALK after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
| SK-N-SH | EC50 | 1988 nM | Antiproliferative activity against human SK-N-SH cells expressing EML4-ALK F1174L mutant after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | [PMID: 26568289] |
19 records · Scroll to view more